HIV/AIDS 2019 Scientific meeting program highlights
Programme highlights: HIV treatment and cure science
The 10th IAS Conference on HIV Science (IAS 2019) will showcase many exciting advances in HIV treatment strategies and the search for a cure, with a significant focus on moving scientific
knowledge into policy and practice. Take a look at some of the abstracts, plenary talks, and sessions that will highlight these topics at the conference.
Examples of abstracts related to HIV treatment and cure science include:
New data from the ATLAS study of a long-acting injectable two-drug regimen for the treatment of HIV
Latest findings on the
safety and efficacy of switching to a single-tablet regimen containing bictegravir, emtricitabine, and tenofovir alafenamide (B/F/TAF)
Results of a large cohort study of renal function trajectories after
switching to tenofovir alafenamide (TAF) from tenofovir disoproxil fumarate (TDF)
Progress toward a functional cure, including new data on the safety and activity of vesatolimod, a toll-like receptor 7 agonist,
in people living with HIV
Important analysis of long-term outcomes for adolescents born with HIV in six African countries
Results from a study investigating interventions to increase viral suppression among transgender
women in the US
Innovativetechnologies that could improve treatment delivery in developing countries, such as an ATM-style machine that dispenses medication and allows patients to communicate with
tele-pharmacists
Updates on the potential link between dolutegravir (DTG) and neural tube birth defects.
Plenaries
Scaling up treatment in resource-constrained settings: What will it take to achieve the last 90? by Gloria Maimela, Wits RHI, South Africa
Barriers to access to diagnosis and treatment by Ingrid Bassett, Massachusetts General Hospital, United States
Primary HIV infection: An opportunity not to be missed? by John Frater, Oxford University, United Kingdom
Co-morbidities by Esteban Martínez, University of Barcelona, Spain
Stem cell and genome editing for HIV cure by Paula Cannon, University of
Southern California, United States
Sessions
ART: Trials and tribulations
Same-day ART, one size fits all?
HIV and pregnancy, beyond Dolutegravir
Paediatric HIV infection: It's never too early
#RecognizeAndOptimize:
Pediatrics and adolescent HIV
Pathogenesis: And the band plays on
Co-morbidities: No organ left behind
Deadly partners: HIV and co-infections
50 shades of reservoirs
Mission remission: Challenge accepted
Achieving
HIV control
Keep control: Elite and post-treatment controllers
Hide and seek: Reservoir and strategies to target them
What is the cure, why do we need it and how do we get there?
IAS 2019 news and reminders
Apply for a Mexican visa today Individuals travelling to Mexico City for IAS 2019 must possess the required documentation to enter Mexico. Delegates who need
a visa are strongly recommended to apply before 31 May 2019. Learn more
Host an Affiliated Independent Event Apply to host an Affiliated Independent Event at IAS 2019 and benefit from our diverse network of followers to increase the visibility and promotion of your event.
Learn more
